Porto's i3S Maps a Path to Personalised Vaccines Against Colorectal Cancer
Researchers at Porto's i3S institute have validated a strategy for personalised therapeutic vaccines against colorectal cancer, identifying tumour neoantigens that could train a patient's immune system to attack the disease.